“Bioidentical” can make a treatment sound reassuring before you know what is actually in it. The term refers to a hormone’s molecular relationship to hormones made by the body. It does not, by itself, describe a product’s approval status or prove that it is safer.
Some FDA-approved estradiol and progesterone medicines fit that description. Compounded preparations may use the same language. Keeping those categories separate helps you ask more useful questions than whether a treatment sounds natural.
The meaningful question is which exact product is proposed, and why it is appropriate for you.
Ask for the name on the prescription
An approved drug has undergone FDA review for its labeled use. Compounded drugs are prepared under a different framework and are not FDA approved; FDA does not verify their safety, effectiveness, or quality before marketing. Ingredient familiarity does not close that evidence gap.
Ask for the drug name, route, formulation, and pharmacy. If the description stops at “custom hormones,” request the details in writing before you pay for a treatment package.
Reading behind this section: FDA: compounding questions and answers
Understand the reason for compounding
ACOG advises against routinely prescribing compounded bioidentical menopausal hormone therapy when FDA-approved formulations are available. A particular patient may have a need that a commercially available product does not meet, but that calls for an explanation of the specific clinical reason.
Personalization is not itself proof of better outcomes. Ask what problem the compounded product solves, what alternatives were considered, and what uncertainty remains. The local versus systemic guide helps clarify another part of that product discussion.
Reading behind this section: ACOG: compounded bioidentical hormone therapy
Keep testing claims in perspective
A polished report or a promise to “balance” hormones is not a substitute for a symptom assessment and a medical history. Ask how a proposed test would change the treatment decision and whether the method is supported for that purpose. Do not assume that more measurements necessarily create a safer prescription.
The HRT overview starts with the symptoms you want help with. That is a more grounded starting point than trying to match a promotional ideal of perfect hormone levels.
Reading behind this section: ACOG: compounded bioidentical hormone therapy · ACOG: hormone therapy for menopause
Read the care offer in full
Look beyond the wording on a bottle. Confirm the prescriber’s authority to treat you, the pharmacy, total recurring charges, and the plan for reviewing benefits and unwanted effects. Our online-care shortlist separates paid visibility from confirmed service information.
If an offer implies that a compounded medicine avoids the risks associated with approved hormones, ask for evidence specific to that formulation. A different regulatory pathway does not establish freedom from the pharmacologic risks of its ingredients.
Reading behind this section: FDA: BeSafeRx · FDA: compounding questions and answers · ACOG: compounded bioidentical hormone therapy
Our source notes
- FDA: compounding questions and answers
Compounded medication is not FDA-approved.
- ACOG: compounded bioidentical hormone therapy
Clinical consensus distinguishes FDA-approved bioidentical medicines from compounded preparations.
- ACOG: hormone therapy for menopause
Clinical patient guidance; individual history and the actual product label still govern treatment decisions.
- FDA: BeSafeRx
Official tools for checking an online pharmacy.
